Resiniferatoxin for detrusor instability refractory to anticholingergics

International Braz J Urol

Volumn 30, Issue 1, 2004, Pages 53-58

  Palma, Paulo C R ^a   Thiel, Marcelo ^a,b   Riccetto, Cássio L Z ^a   Dambros, Miriam ^a   Miyaoka, Ricardo ^a   Rodrigues Netto Jr , N ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Bladder; Bladder instillations; Toxins; Urination disorders; Urodynamics

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; RESINIFERATOXIN;

ADULT; AGED; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DISEASE DURATION; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HUMAN; INVOLUNTARY MOVEMENT; SYMPTOMATOLOGY; TREATMENT OUTCOME; URGE INCONTINENCE; URINARY URGENCY; URODYNAMICS; UROGENITAL SYSTEM EXAMINATION;

EID: 1642485779     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382004000100012     Document Type: Article

References (14)

1. Abrams P, Blaivas JG, Stanton SL, Andersen JT: The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl. 1988; 114: 5-19.
2. De Groat WC: A neurological basis for the overactive bladder. Urology. 1997; 50 (suppl. 6A): 36-52.
3. O'Reilly B, Kosaka AH, Knight GF, Chang TK, Ford AP, Rymer JM, et al.: P2X receptors and their role in female idiopathic detrusor instability. J Urol. 2002; 167: 157-64.
4. Brading AF: A myogenic basis for the overactive bladder. Urology. 1997; 50 (suppl. 6A): 57-67.
5. Chapple CR: Muscarinic receptor antagonists in the treatment of overactive bladder. Urology. 2000; 55 (suppl. 5A): 33-46.
6. Szallasi A, Blumberg PM: Resiniferatoxin and analogs provide novel insights into the pharmacology of the vanilloid receptor. Life Sci. 1990; 47: 1399-408.
7. Silva C, Ribeiro MJ, Cruz F: The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol. 2002; 168: 575-9.
8. Szallasi A, Conte B, Goso C, Blumber PM, Manzini S: Vanilloid receptors in the urinary bladder: Regional distribution, localization on sensory nerves, and species-related differences. Naunyn schmiedebergs arch pharmacol [Multi]. 1993; 347: 624.
9. Yokoyama O, Komatsu K, Kodama K, Yotsuyanagi S, Niikura S, Namiki M: Diagnostic value of intravesical lidocaine for overactive bladder. J Urol. 2000; 164: 340-3.
10. Lazzeri M, Beneforti P, Turini D: Urodynamic effects of intravesical resiniferatoxin in humans: Preliminary results in stable and unstable detrusor. J Urol. 1997; 158: 2093-6.
11. Cruz F, Guimarães M, Silva C, Reis M: Supression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet. 1997; 350: 640-1.
12. Hayes P, Meadows HJ, Gunthorpe MJ, Harries MH, Duckworth DM, Cairns W, et al.: Cloning and functional expressions of a human orthologue of rat vanilloid receptor-1. Pain. 2000; 88: 205-215.
13. OSteers WD: Rat: overview and innervation. Neurourol Urodyn. 1994; 13: 97-118.
14. Avelino A, Cruz C, Nagy I, Cruz F: Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience. 2002; 109: 787-98.